STOCK TITAN

Director at American Vanguard (AVD) receives 31,872 deferred stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Macicek Steven D reported acquisition or exercise transactions in this Form 4 filing.

American Vanguard Corp director Steven D. Macicek reported an equity award of 31,872 deferred stock units (DSUs) of common stock. The units were granted at no cash cost as part of the company’s compensation program for non‑management directors in connection with the 2026 annual stockholders’ meeting.

Each DSU represents the right to receive one share of common stock upon settlement, which occurs when Macicek’s board service ends, upon a change of control, or upon his death. After this grant, he directly holds 80,711 shares or share-equivalent units. DSUs are nontransferable during service and carry neither voting nor dividend rights until they settle.

Positive

  • None.

Negative

  • None.
Insider Macicek Steven D
Role null
Type Security Shares Price Value
Grant/Award Common Stock 31,872 $0.00 --
Holdings After Transaction: Common Stock — 80,711 shares (Direct, null)
Footnotes (1)
  1. [object Object]
DSUs granted 31,872 units Deferred stock units awarded to director on 2026-06-04
Transaction price per DSU $0.0000 per unit Equity award granted at no cash cost
Holdings after transaction 80,711 shares/units Total common stock or share-equivalent units following grant
DSU settlement triggers 3 triggers Board service end, change of control, or death
Voting and dividend rights None before settlement DSUs are nontransferable and carry no voting or dividend rights
deferred stock units ("DSU") financial
"These represent deferred stock units ("DSU") that were awarded as part of the Company's compensation program"
change of control financial
"settlement (which occurs on the earlier to occur of either (i) when the recipient's service ... (ii) a change of control"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
non-management directors financial
"awarded as part of the Company's compensation program for non-management directors in connection with the 2026 annual stockholders' meeting"
voting rights financial
"During the remaining term of service, DSUs are nontransferable and carry neither voting nor dividend rights"
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
dividend rights financial
"DSUs are nontransferable and carry neither voting nor dividend rights"
Dividend rights are a shareholder’s entitlement to receive a portion of a company’s profits when the board declares a payout, similar to having a ticket that lets you take a slice of a shared pie. These rights determine who gets paid, how much and in what order (different share classes can have priority), so they matter to investors because they affect expected income, trade value and how quickly cash returns to owners.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Macicek Steven D

(Last)(First)(Middle)
15440 LAGUNA CANYON ROAD, SUITE 100

(Street)
IRVINE CALIFORNIA 92618

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMERICAN VANGUARD CORP [ AVD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026A31,872(1)A$080,711D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These represent deferred stock units ("DSU") that were awarded as part of the Company's compensation program for non-management directors in connection with the 2026 annual stockholders' meeting. Each DSU constitutes the right to receive one share of the Company's common stock upon settlement (which occurs on the earlier to occur of either (i) when the recipient's service on the Company's board is concluded, (ii) a change of control or (iii) the recipient's death). During the remaining term of service, DSUs are nontransferable and carry neither voting nor dividend rights. DSUs are subject to the terms and conditions of the Company's standard form DSU agreement.
/s/ STEVEN D. MACICEK06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did American Vanguard (AVD) report for Steven D. Macicek?

American Vanguard reported that director Steven D. Macicek received 31,872 deferred stock units (DSUs) of common stock. The award was granted at no cash cost as part of the company’s compensation program for non‑management directors tied to the 2026 annual stockholders’ meeting.

How many American Vanguard DSUs did Steven D. Macicek receive and at what price?

Steven D. Macicek was granted 31,872 deferred stock units (DSUs) of American Vanguard common stock. The Form 4 lists the transaction price per share as 0.0000, reflecting that this was a compensation-related equity award rather than an open-market purchase for cash.

What are American Vanguard deferred stock units (DSUs) awarded to directors?

American Vanguard DSUs are compensation awards for non‑management directors, each representing the right to receive one share of common stock upon settlement. Settlement occurs when board service concludes, upon a change of control, or upon the recipient’s death, and DSUs carry no voting or dividend rights before settlement.

When do Steven D. Macicek’s American Vanguard DSUs settle into common stock?

Steven D. Macicek’s DSUs settle into one share of American Vanguard common stock per unit on the earlier of three events: when his service on the company’s board concludes, a change of control occurs, or his death, according to the terms described for the deferred stock units.

How many American Vanguard shares does Steven D. Macicek hold after this DSU grant?

Following the reported DSU grant, Steven D. Macicek directly holds 80,711 shares or share-equivalent units of American Vanguard common stock. This total reflects his position after receiving 31,872 deferred stock units awarded as part of the non‑management director compensation program.

Do American Vanguard DSUs for directors have voting or dividend rights before settlement?

The DSUs awarded to American Vanguard non‑management directors do not provide voting or dividend rights before settlement. During the remaining term of board service, these deferred stock units are nontransferable and carry neither voting nor dividend rights, as described in the award’s terms.